Lucira Health Stock Z Score
LHDXDelisted Stock | USD 0.03 0 12.25% |
Lucira |
Lucira Health Company Z Score Analysis
Lucira Health's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Lucira Health Z Score | -0.19 |
Most of Lucira Health's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lucira Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Lucira Health has a Z Score of -0.19. This is 102.81% lower than that of the Healthcare sector and 104.38% lower than that of the Medical Devices industry. The z score for all United States stocks is 102.18% higher than that of the company.
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
All Next | Launch Module |
Lucira Fundamentals
Return On Equity | -1.12 | |||
Return On Asset | -0.42 | |||
Profit Margin | (0.68) % | |||
Operating Margin | (0.65) % | |||
Current Valuation | 19.89 M | |||
Shares Outstanding | 40.6 M | |||
Shares Owned By Insiders | 10.12 % | |||
Shares Owned By Institutions | 23.00 % | |||
Number Of Shares Shorted | 676.85 K | |||
Price To Book | 0.19 X | |||
Price To Sales | 0.04 X | |||
Revenue | 93.06 M | |||
Gross Profit | 11.66 M | |||
EBITDA | (60.85 M) | |||
Net Income | (64.83 M) | |||
Cash And Equivalents | 74.96 M | |||
Cash Per Share | 1.87 X | |||
Total Debt | 48.23 M | |||
Debt To Equity | 0.26 % | |||
Current Ratio | 3.81 X | |||
Book Value Per Share | 1.50 X | |||
Cash Flow From Operations | (100.88 M) | |||
Short Ratio | 0.24 X | |||
Earnings Per Share | (3.14) X | |||
Price To Earnings To Growth | (0.27) X | |||
Target Price | 0.5 | |||
Number Of Employees | 221 | |||
Beta | 3.76 | |||
Market Capitalization | 18.36 M | |||
Total Asset | 240.35 M | |||
Retained Earnings | (128.54 M) | |||
Working Capital | 155.95 M | |||
Z Score | -0.19 | |||
Net Asset | 240.35 M |
About Lucira Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Lucira Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lucira Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lucira Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Lucira Health information on this page should be used as a complementary analysis to other Lucira Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Lucira Stock
If you are still planning to invest in Lucira Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lucira Health's history and understand the potential risks before investing.
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
CEOs Directory Screen CEOs from public companies around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |